Tamper-resistant OxyContin receives FDA approval

04/5/2010 | Wall Street Journal, The

Purdue Pharma gained FDA approval to market a tamper-resistant formulation of pain drug OxyContin. The agency said the version "will likely result in less abuse by snorting or injection" because its active ingredient turns into a gel when dissolved in liquid, but it can still be abused "by simply ingesting larger doses than are recommended."

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC